Treatment with placenta-derived mesenchymal stem cells mitigates development of bronchiolitis obliterans in a murine model
Treatment with placenta-derived mesenchymal stem cells mitigates development of bronchiolitis obliterans in a murine model is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Treatment with placenta-derived mesenchymal stem cells mitigates development of bronchiolitis obliterans in a murine model have?
Treatment with placenta-derived mesenchymal stem cells mitigates development of bronchiolitis obliterans in a murine model has 30 citations in the OpenAlex counts ScholarIQ stores.
When was Treatment with placenta-derived mesenchymal stem cells mitigates development of bronchiolitis obliterans in a murine model published?
Treatment with placenta-derived mesenchymal stem cells mitigates development of bronchiolitis obliterans in a murine model has 2013 year in the ScholarIQ index.
What is the open-access status of Treatment with placenta-derived mesenchymal stem cells mitigates development of bronchiolitis obliterans in a murine model?
Treatment with placenta-derived mesenchymal stem cells mitigates development of bronchiolitis obliterans in a murine model has bronze oa status in the ScholarIQ index.
What is the DOI of Treatment with placenta-derived mesenchymal stem cells mitigates development of bronchiolitis obliterans in a murine model?
The DOI for Treatment with placenta-derived mesenchymal stem cells mitigates development of bronchiolitis obliterans in a murine model is on the source record.
What is the PMID of Treatment with placenta-derived mesenchymal stem cells mitigates development of bronchiolitis obliterans in a murine model?
The PMID for Treatment with placenta-derived mesenchymal stem cells mitigates development of bronchiolitis obliterans in a murine model is on the source record.
What is the OpenAlex record for Treatment with placenta-derived mesenchymal stem cells mitigates development of bronchiolitis obliterans in a murine model?
The OpenAlex for Treatment with placenta-derived mesenchymal stem cells mitigates development of bronchiolitis obliterans in a murine model is on the source record.